AI Opportunity and Risk Context
The Double-Edged Sword: Navigating AI’s Opportunity and Risk in Pharma
The accelerating adoption of AI in healthcare brings both immense potential and significant risks, ranging from data privacy, security, and regulatory uncertainty to ethical dilemmas and biased outcomes.
AI Risk Classification: We use an AI Risk Matrix for systematic project classification into four levels: Unacceptable, High, Limited, and Minimal Risk.
The Double-Edged Sword of AI in Pharma: Innovation Potential vs. Regulatory or Reputation Risks: We help you balance the need for innovation with the inherent risks of AI, ensuring you minimize risk in proportion to both the scale and the potential rewards.
Structured Frameworks for AI Opportunity Assessment: We provide a comprehensive, risk-based AI Governance Playbook built on international best practices and frameworks like the EU AI Act. We utilize horizon scanning to identify emerging trends, technologies, and opportunities to empower the business.
